Malignant germ cell tumors in childhood: Results of the first Italian cooperative study "TCG 91"

Medical and Pediatric Oncology

Volumn 41, Issue 5, 2003, Pages 417-425

  Curto, Margherita Lo ^a,c   Lumia, Francesca ^a   Alaggio, Rita ^d   Cecchetto, Giovanni ^d   Almasio, Piero ^d   Indolfi, Paolo ^d   Siracusa, Fortunato ^d   Bagnulo, Serenella ^d   De Bernardi, Bruno ^d   De Laurentis, Tina ^b   Di Cataldo, Andrea ^d   Tamaro, Paolo ^d  

^a UNIVERSITY OF PALERMO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c Dipartimento Materno Infantile   (Italy)

^d NONE

Author keywords

Carboplatin; Malignant germ cell tumors; Risk factors in malignant germ cell tumors; Seminoma

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; BACK; BLOOD TOXICITY; BRAIN HEMORRHAGE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG FATALITY; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; RELAPSE; REMISSION; SEPSIS; SIDE EFFECT; TESTIS CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; GERMINOMA; HUMANS; INCIDENCE; ITALY; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0141960354     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10324     Document Type: Article

References (40)

1. Miller RW, Dalager NA. U.S. Childhood cancer deaths by cell types (1960-1968). J Pediatr 1974;85:644-650.
2. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: A clinical and pathological analysis of diseases. Cancer 1976;38:2404-2419.
3. Einhorn LH, Donohue J. Cis-diamindicloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Inter Med 1977;87:293-298.
4. Baranzelli MC, Kramar A, Bouffet E, et al. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 1999;17:1212-1218.
5. Kapoor G, Advani SH, Nair CN, et al. Pediatric germ cell tumor, an experience with BEP. J Pediatr Hematol Oncol 1995;17:318-324.
6. Marina N, Fontanesi J, Kun L, et al. Treatment of childhood germ cell tumors, review of the St. Jude experience from 1979 to 1988. Cancer 1992;70:2568-2574.
7. Gobel U, Calaminus G, Teske C, et al. BEP/VIP bei kindern und jugendlichen mit malignen nichttestikularen keimzelltumoren. Klin Padiatr 1993;205:231-240.
8. Mann JR, Raafat F, Robinson K, et al. UKCGSG'S germ cell tumor (GCT) studies: Improving outcome for children with malignant extracranial non gonadal tumors-carboplatin, etoposide and bleomycin are effective and less toxic than previous regimens. Med Pediatr Oncol 1998;30:217.
9. Mann JR, Raafat F, Robinson K, et al. The United Kingdom children's cancer study group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 2000;22:3809-3818.
10. Ablin AR, Railo MD, Ramsay NKC, et al. Results of treatment of malignant germ cell tumors in 93 children: A report from the children cancer study group. J Clin Oncol 1991;9:1782-1792.
11. Germa-Lluch JR, Begent R, Bagshawe KD. Tumor markers levels and prognosis in malignant teratoma of the testis. Br J Cancer 1980;42:850-854.
12. Mann JR, Pearson D, Barrett A, et al. Results of the United Kingdom children's cancer study group's malignant germ cell tumor studies. Cancer 1989;63:1657-1667.
13. Mead GM, Stenning SP, Parkinson MC, et al. The second medical research council study of prognostic factors in non seminoumatous germ cell tumors. J Clin Oncol 1992;10:85-94.
14. Gobel U, Haas G, Calaminus G, et al. Treatment of germ cell tumors in children: Results of European trials for testicular and non-testicular primary sites. Crit Rev Oncol Hematol 1990;10:89-98.
15. Aass N, Olbjorn K, Cavallin-Stahl E, et al. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: A multicenter experience. J Clin Oncol 1991;9:818-826.
16. Dehner LP. Gonadal and extragonadal germ cell neoplasms: Teratomas in childhood. In: Finegold M, Benington JL, editors. Pathology of neoplasia in children and adults. Philadelphia, PA: WB Saunders; 1986. pp 282-312.
17. Miller AB, Frop MB, Hoogstraten B, et al. Reporting results of cancer treatment. Cancer 1981;42:207-214.
18. Flamant F, Schwartz L, Delons E, et al. Nonseminomatous malignant germ cell tumors in children, multidrug therapy in stages III e IV. Cancer 1984;54:1687-1691.
19. Calaminus G, et al. Values of healthy newborns until the age of two years. Klin Pädiatr 1991;203:246-250.
20. Frazier LA, Grier HE, Green DM. Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin. Med Pediatr Oncol 1996;27:69-73.
21. Baranzelli MC, Flamant F, De Lumley L, et al. Treatment of non-metastatic, non-seminomatous malignant germ cell tumors in childhood: experience of the "Societé Francaise d'Oncologie Pediatrique" MGCT 1985.1989 study. Med Pediatr Oncol 1993;21:395-401.
22. Gobel U, Calaminus G, Engert J, et al. Malignant pediatric extracranial non-testicular germ cell tumor (GCTs), the German experience. In: Jones WG, Appleyard I, Harnden P, Joffe JK, editors. Germ cell tumor IV conference. London: John Libbey and Co.; 1998. pp 205-211.
23. Haas RJ, Schmidt P, Gobel U, et al. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Klin Pädiatr 1999;211:300-304.
24. Gels ME, Hoekstra HJ, Sleijfer DT, et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single center 10 year experience. J Clin Oncol 1995;13:1188-1194.
25. Bosl GJ, Geller NL, Bajorin D, et al. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 1998;6:1231-1238.
26. Lopes LF, de Camargo B, Dondonis M, et al. Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: results of the Brazilian germ cell tumor study. Med Pediatr Oncol 1995;25:396-399.
27. Smalley SR, Evans RG, Richardson RL, et al. Radiotherapy as initial treatment for bulky stage II testicular seminomas. J Clin Oncol 1985;3:1333.
28. Warde P, Gospodarowicz M, Panzarella T, et al. Management of stage II seminoma. J Clin Oncol 1998;16:290.
29. Clemm C, Hartenstein R, Willich N, et al. Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma. Cancer 1986;58:2203-2207.
30. Horwick A. Chemotherapy of seminoma. Eur Urol 1993;2:26-28.
31. Kaye SB, Mead GM, Fossa S, et al. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor prognosis metastatic nonseminomatous germ cell tumor: a randomized medical research council/European organization for research and treatment of cancer study. J Clin Oncol 1998;16:692-701.
32. Bajorin DF, Mazumdar M, Meyers M, et al. Metastatic germ cell tumors: modeling for response to chemotherapy. J Clin Oncol 1998;16:707-715.
33. Moran CA, Suster S, Przygodzki RM, et al. Primary germ cell tumors of the mediastinum. II. Mediastinal sarcomas-clinicopathologic and immunohistochemical study of 120 cases. Cancer 1997;80:691-698.
34. Moran CA, Suster S, Koss MN. Primary germ cell tumors of the mediastinum. III: Yolk sac tumor, embryonal carcinoma, choriocarcinoma and combined nonseminomatous germ cell tumors of the mediastinum-clinicopathologic and immunohistochemical study of 64 cases. Cancer 1997;80:699-707.
35. Goss PE, Schwertfeger L, Blackstein ME, et al. Extragonadal germ cell tumors. Cancer 1994;73:1971-1979.
36. Steyerberg EW, Keizer HJ, Fossa SD, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13:1177-1187.
37. Stenning SP, Parkinson MC, Fisher C, et al. Postchemotherapy residual masses in germ cell tumor patients, content clinical features and prognosis. Cancer 1998;83:1409-1419.
38. Logothetis CJ, Samuels ML, Trindade A, et al. The growing teratoma syndrome. Cancer 1982;50:1629-1635.
39. Debono DJ, Heilman DK, Einhorn LH, et al. Decision analysis avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 1997;15:1455-1464.
40. Gerl A, Clemm C, Lamerz R, et al. Cisplatin based chemotherapy of primary extragonadal germ cell tumors, a single institution experience. Cancer 1996;77:526-532.